Linagliptin

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Linagliptin and local guidelines before prescribing.

DPP-4 inhibitor

Mechanism

DPP-4 inhibitor raising incretin levels.

Uses

Type 2 diabetes.

Dosing

Side effects

Nasopharyngitis, pancreatitis (rare), arthralgia, bullous pemphigoid.

Interactions

Rifampicin reduces effect; sulfonylureas increase hypoglycaemia.

Contraindications and cautions

Pancreatitis history

Monitoring

HbA1c

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

No adjustment

Overdose and reversal

Supportive

Special advice

No renal dose adjustment; stop if pancreatitis suspected.

More from the textbook: uses, cautions and other points
Where it is discussed in the book